Practice Pearls
What can we help you find?
Cardiovascular panel of experts provide an overview and mechanism of action for the direct oral anticoagulants.
Expert panel discusses a risk-benefit comparison for factor VIII concentrate versus emicizumab for the treatment of hemophilia.
Acute myeloid leukemia (AML) is the most frequently occurring cause of acute leukemia in adults.
Although HCV is now curable, there are varying factors that must be considered prior to starting treatment.
The first step in identifying the appropriate patients with hemophilia for prophylaxis is understanding the breadth of severity.
Myriad factors are involved in determining the appropriate care pathway for patients with acute myeloid leukemia.
The importance of inpatient/outpatient (IPOP) unit induction and its role in the treatment of acute myeloid leukemia.
Experts in AML discuss the impact of outpatient treatment options on the quality of life for patients and review available consolidation treatments.
Experts in AML discuss the impact of outpatient treatment options on the quality of life for patients and review available consolidation treatments.
Review of the pharmacist’s role in outpatient care for acute myeloid leukemia.
Description of the traditional inpatient administrations versus outpatient treatment processes in acute myeloid leukemia.
Experts discuss the identification and Medical Utilization Evaluation of patients with newly diagnosed acute myeloid leukemia.